Navigation Links
Align Technology Asserts ClearCorrect Complaint Is Without Merit
Date:2/18/2009

SANTA CLARA, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the Company has been notified of a purported declaratory judgment action filed against the Company on February 17, 2009 by ClearCorrect, Inc. in the United States District Court for the Southern District of Texas. Align Technology became aware of the filing on February 17, 2009, but has not been served with a copy of the Complaint.

In the Complaint, assigned case # H-09-470 and captioned ClearCorrect, Inc., Plaintiff, vs. Align Technology, Inc., Defendant, ClearCorrect alleges that a "controversy exists between Align and ClearCorrect concerning the validity of Align's patents that relate to the manufacture and sale of a clear aligner therapy system" and regarding "the infringement of Align's patents" by ClearCorrect. The Complaint seeks a judgment declaring that unidentified Align patents are invalid and unenforceable and that ClearCorrect does not infringe the unidentified Align patents.

Align Technology is not currently involved in any litigation with ClearCorrect, nor has Align previously communicated with ClearCorrect regarding the subject matter of the Complaint or any of Align's 165 issued patents. ClearCorrect's Complaint is entirely unrelated to a previous lawsuit filed by Align Technology against Dr. Willis Pumphrey, ClearCorrect's CEO, for breach of contract, trademark infringement and copyright infringement. That lawsuit was settled to Align's satisfaction in 2007 by the payment of over $330,000 to Align by Dr. Pumphrey and a stipulation by the parties that Dr. Pumphrey was decertified by Align and is no longer authorized to treat patients with Invisalign products.

Align has reviewed the allegations contained in the ClearCorrect filing and believes they are without merit. The Company intends to vigorously defend itself against the Complaint.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find an Invisalign-trained doctor in your area, please visit www.invisalign.com or call 1-800-INVISIBLE.

    Investor Relations Contact          Press Contact
    Shirley Stacy                       Shannon Mangum Henderson
    Align Technology, Inc.              Ethos Communication, Inc.
    (408) 470-1150                      (678) 540-9222
    sstacy@aligntech.com                align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
2. Align(R) Daily Probiotic Supplement Meets New Consumer Guidelines
3. Align Technology Executives to Present at ROTH 21st Annual OC Growth Stock Conference
4. Align Technology Announces Fourth Quarter and Fiscal 2008 Results
5. MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development
6. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
7. Tennessee Hospital Association Selects PivotHealth To Provide Hospital-Physician Alignment Services
8. FDA Clears Expanded Labeling for the Invisalign System
9. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
10. Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
11. Align Technology Announces Third Quarter Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages ... Real Impact contest from Impact Teen Drivers and California Casualty. Entries from students ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer messages ...
(Date:1/19/2017)... ... 2017 , ... Bill Howe Plumbing, Heating & Air in San Diego announces ... Healthy is Your Heart Drawing Contest The drawing contest asks children to draw ... Heating & Air receives over 600 entries. The culmination of the joint effort will ...
(Date:1/19/2017)... ... ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, announced today that it ... years SFI has been recognized as the world’s leader in Intelligent Sales Outsourcing Solutions. ... market. The new clients include: Panacea Pro, Campseekers, Contentmart, Stress Pal, Ariello, Inc. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Breast Surgery Symposium, a conference where hundreds of surgeons from over fifteen different ... Covering topics from cosmetic breast augmentation to breast reconstruction for breast ...
(Date:1/18/2017)... Austin, TX (PRWEB) , ... January 18, 2017 , ... ... million people opened a global discussion about the benefits of fidgeting to relieve stress ... Lyon and Jym Daniel. Their Think Ink Pen had just completed a successful ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... SUNNYVALE, Calif. , Jan. 19, 2017 ... that its CyberKnife® and TomoTherapy® Systems continue to set ... systems received the highest composite overall user satisfaction rating ... to the Q4 2016 MD Buyline Market Intelligence Briefing™. ... achieved the highest composite ratings among industry peers for ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
(Date:1/19/2017)... SAN FRANCISCO , January 19, 2017 The global  ... a new report by Grand View Research, Inc. The heightening prevalence of cardiac ... governing the growth of Pacemaker globally. In addition, technological enhancements in these devices ... Reading ... Grand View Research Logo ...
Breaking Medicine Technology: